Europe Bariatric Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The European Bariatric Surgery Market is Segmented by Device (Assisting Devices, Implantable Devices, and Other Devices) and Geography (Germany, United Kingdom, France, Italy, Spain and Rest of Europe). The report offers the value (in USD million) for the above segments.

Europe Bariatric Surgery Market Size

Single User License
Team License
Corporate License
Book before:
View Global Report
Europe Bariatric Surgery Market Summary
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 15.00 %
Market Concentration Medium

Major Players

Europe Bariatric Surgery Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Europe Bariatric Surgery Market Analysis

The European bariatric surgery market is expected to record a CAGR of about 15% over the forecast period.

COVID-19 had a significant impact on the demand for bariatric surgery in Europe due to the strict lockdown imposition during the initial stages of the pandemic. For instance, the article published by Springer in February 2021, mentioned that in the United Kingdom, most of the elective bariatric surgeries and clinics were canceled early after the declaration of the pandemic. The average canceled elective bariatric surgery operation per week was 9. Such reduction in the bariatric surgeries had a notable impact on the growth of the narket over the pandemic period. However, the resumption of bariatric surgeries after the relaxation of strict lockdown procedures during the post-pandemic period is expected to boost the growth of the market over the forecast period.

Certain factors that are responsible for the growth of this market are the increase in the obese population, the prevalence of diabetes and heart diseases, government initiatives to curb obesity, and insurance coverage of surgeries. According to the WHO European Regional Obesity Report 2022, data updated in May 2022, overweight and obesity affect almost 60% of adults and nearly one in three children (29% of boys and 27% of girls) in the WHO European Region. Thus, the increasing prevalence of obesity in the region is expected to accelerate bariatric surgery in the region. In Europe, there is a rapid growth in the obese population, which is leading to high demand for obesity treatments. The number of bariatric surgeries in Europe is growing constantly, which has generated a demand for the devices used for bariatric surgery. As per an article titled "European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline" published in August 2022, in the United Kingdom, European Association for the Study of Obesity (EASO) targets to promote the expansion of high-quality centers for obesity surgery, including educating and training future surgeons. According to the National Institute of Health, dta updated in 2020 the United Kingdom has the highest levels of obesity and overweight people than anywhere else in Western Europe.

According to an BMJ article published in April 2022, the United Kingdom government revoked its USD 131 million financing award for weight control services in England. Over EUR 70 million (USD 74.44 million) of the funds, which were split between the NHS and councils, were used to support programs including weight control groups, one-on-one coaching, and specialized clinical care. This is expected to promote market growth in the region.

As per an article published by IBI Healthcare Institure in June 2022, the gastric bypass procedure's overall cost will vary depending on several variables. These include your own BMI, the extent of the postoperative care, and whether nutritional guidance is provided before and/or following your treatment. The Gastric bypass cost is around EUR 12,490 (USD 13,283.11) and the Gastric band bypass cost is about EUR 15,450 (USD16,431.07) in the United Kingdom. Thus, the high price for the procedures is expected to drive the market growth in the region. Also, the WHO estimates that 89% of Irish men and 85% of women will be overweight by 2030. WHO also suggests that countries that do not have noted obesity levels, like Sweden and Austria, will also see a sharp rise in the coming future. Thus, the sharp rise in the obese population in Europe is expected to be influential in propelling the growth of the European bariatric surgery market. This, along with government initiatives to overcome the obesity, is anticipated to lead to the growth of the European bariatric surgery market.

Therefore the above-mentioned factors are expected to drive the market growth in the region during the forecast period.

Europe Bariatric Surgery Market Trends

Gastric Balloons Segment is Expected to Witness the Highest CAGR in the Market Over the Forecast Period

The gastric balloons segment of the European bariatric surgery market is expected to experience the highest growth rate. This is primarily attributed to the rising demand for these devices in the European region.

Due to the low treatment cost in comparison to other treatments and the high prevalence of obesity, the market is expected to rise. One of the main reasons for the rising prevalence of obesity is the adoption of a sedentary lifestyle. Other contributing factors include an unhealthy diet and alcohol misuse. According to WHO European Regional Obesity Report 2022, data updated in May 2022, approximately 60% of adults and nearly one in three children that are 29% of boys and 27% of girls are overweight or obese in the WHO European Region. Similarly, as per an article published by BMJ Journal in May 2022, obesity is causing 200,000 cancer cases. In Europe, 8% of children under the age of five, one in three children of school age, and 59% of adults are overweight or obese in 2020. This rising number of obesity in the population of the region is expected to give rise to bariatric surgeries and thereby drive segmental growth.

Additionally, the efficacy of gastric balloons in bariatric surgery is expected to drive the demand for gastric balloons, thereby boosting segment growth. For instance, the data published by Mayo Clinic in September 2021 mentioned that about 7% to 15% of the body weight loss would happen after the placement of an intragastric balloon during the six months. The article also mentioned that excess weight loss ranges from 30% to 47%. Such benefits related to gastric balloons in weight loss procedures are expected to boost the growth of the studied segment over the forecast period. 

Therefore the rising demand for implantable devices is expected to contribute to the faster growth of this segment.

Europe Bariatric Surgery Market: Estimated Prevalence of Obesity (in Percentage), By Country, Europe, 2030

Germany is Expected to Hold Major Market Share in the the Market Over the Forecast Period

Germany is expected to hold a significant share of the market and is expected to do the same in the Forecast Period.

The increase in the obese population and the prevalence of diabetes and heart disease are some of the factors expected to drive the market in the country. As per an article published by Elsevier Journal in February 2022, the prevalence of comorbid depression and obesity was 1.3% (95% CI 0.8-2.0) in men and 2.0% (95% CI 1.3-3.0) in women. Similarly, as per another article published by RKI in September 2022, 53.5% of adults in Germany are overweight and the prevalence of obesity was observed in men more than in women. The obesity prevalence for both sexes is 19.0%. In both women and men, the frequency of overweight and obesity rises with age. Compared to high-education groups, low-education groups have a much higher prevalence of obesity. Thus, it is anticipated that the country's rising obesity prevalence will boost the need for bariatric surgery there and speed up market growth.

As per an article by MBD published in August 2022, the average price of gastric bypass surgery in Germany is expected to cost around USD 19,000, and the minimum cost is expected to be USD 12,400 and the maximum cost expected to be USD 21,400. Thus, the pricing is expected to expand as the advancement grows and enhances the growth of the segmental growth in the market. According to an Springer article published in February 2022, a person who is obese has a higher risk of getting type 2 diabetes (T2DM), and arterial hypertension, which leads to overall mortality. Consequently, it is essential to have adequate treatment. In Germany, about 20 000 bariatric procedures are carried out annually. Thus, the demand for bariatric procedures in the country is expected to boost the segment in the market.

Therefore, the above-mentioned factors are expected to accelerate the market growth in the country during the forecast period.

Europe Bariatric Surgery Market: Estimated Prevalence of Obesity (in Percentage), By Gender, Germany, 2030

Europe Bariatric Surgery Industry Overview

The European bariatric surgery market is moderately competitive in nature. In terms of market share, a few of the major players are currently dominating the market. Some of the companies are Apollo Endosurgery Inc., Olympus Corporation, EnteroMedics Inc., Johnson & Johnson (Ethicon), and Medtronic PLC.

Europe Bariatric Surgery Market Leaders

  1. Apollo Endosurgery Inc.

  2. Olympus Corporation

  3. EnteroMedics Inc.

  4. Johnson and Johnson (Ethicon)

  5. Medtronic PLC

*Disclaimer: Major Players sorted in no particular order

Europe Bariatric Surgery Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Europe Bariatric Surgery Market News

  • In June 2022, Rhythm Pharmaceuticals, Inc. announced that IMCIVREE is available to patients in Germany.The European Commission granted IMCIVREE marketing authorization for the treatment of obesity and the management of hunger in adults and children aged 6 and older with genetically confirmed loss-of-function biallelic pro-opiomelanocortin, including proprotein convertase subtilisin/kexin type 1 deficiency or biallelic leptin receptor deficiency.
  • In June 2022, European Medicines Agency (EMA) safety committee Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the withdrawal of European Union (EU) marketing authorisations for amfepramone obesity medicines.

European Bariatric Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Definitions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increase in Obese Population

      2. 4.2.2 Prevalence of Diabetes and Heart Diseases

      3. 4.2.3 Government Initiatives to Curb Obesity

      4. 4.2.4 Insurance Coverage of Surgeries

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Knowledge and Awareness in the Region

      2. 4.3.2 High Cost of Surgery

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Device

      1. 5.1.1 Assisting Devices

        1. 5.1.1.1 Suturing Device

        2. 5.1.1.2 Closure Device

        3. 5.1.1.3 Stapling Device

        4. 5.1.1.4 Trocars

        5. 5.1.1.5 Clip Appliers

        6. 5.1.1.6 Other Devices

      2. 5.1.2 Implantable Devices

        1. 5.1.2.1 Gastric Bands

        2. 5.1.2.2 Electrical Stimulation Devices

        3. 5.1.2.3 Gastric Balloons

        4. 5.1.2.4 Gastric Emptyingns

      3. 5.1.3 Other Devices

    2. 5.2 Geography

      1. 5.2.1 Germany

      2. 5.2.2 United Kingdom

      3. 5.2.3 France

      4. 5.2.4 Italy

      5. 5.2.5 Spain

      6. 5.2.6 Rest of Europe

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan Inc.

      2. 6.1.2 Apollo Endosurgery Inc.

      3. 6.1.3 Aspire Bariatrics Inc.

      4. 6.1.4 Covidien PLC

      5. 6.1.5 EnteroMedics Inc.

      6. 6.1.6 Ethicon Inc.

      7. 6.1.7 ReShape Medical Inc.

      8. 6.1.8 TransEnterix Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Bariatric Surgery Industry Segmentation

As per the scope of the report, bariatric surgery is a medical procedure that aids weight loss by either limiting the capacity of the stomach or the absorption of calories. This is the most effective weight-loss therapy available for patients with morbid obesity. Bariatric surgery prevents obesity-related diseases, like diabetes, hypertension, cardiac dysfunction, and fatty liver disease. The European Bariatric Surgery Market is Segmented by Device (Assisting Devices and Implantable Devices, and Other Devices) and Geography (Germany, United Kingdom, France, Italy, Spain, and the Rest of Europe). The report offers the value (in USD million) for the above segments.

By Device
Assisting Devices
Suturing Device
Closure Device
Stapling Device
Trocars
Clip Appliers
Other Devices
Implantable Devices
Gastric Bands
Electrical Stimulation Devices
Gastric Balloons
Gastric Emptyingns
Other Devices
Geography
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
customize-icon Need A Different Region Or Segment?
Customize Now

European Bariatric Market Research FAQs

The Europe Bariatric Surgery Market is projected to register a CAGR of 15% during the forecast period (2024-2029)

Apollo Endosurgery Inc., Olympus Corporation, EnteroMedics Inc., Johnson and Johnson (Ethicon) and Medtronic PLC are the major companies operating in the Europe Bariatric Surgery Market.

The report covers the Europe Bariatric Surgery Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Bariatric Surgery Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Europe Bariatric Surgery Industry Report

Statistics for the 2024 Europe Bariatric Surgery market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Bariatric Surgery analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Europe Bariatric Surgery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)